Elevated risk U.S. Food and Drug Administration

Spectrum Epinephrine bulk API recall: Product discoloration

Recall published 3+ years ago

Product discoloration

Spectrum Prescription & OTC drugs — recalled prescription & otc drugsSpectrum Prescription & OTC drugs — recalled prescription & otc drugs (photo 2)Spectrum Prescription & OTC drugs — recalled prescription & otc drugs (photo 3)Spectrum Prescription & OTC drugs — recalled prescription & otc drugs (photo 4)
4 photos published by U.S. Food and Drug Administration with the recall notice.

The hazard: Drug safety concern

A problem with this medicine prompted the recall. With prescriptions, the first move is a conversation rather than a decision.

What the notice says: Risk Statement: Epinephrine is a critical medication used during life-threatening conditions which can affect any age and any person.

Why it matters: The FDA recorded an enforcement action against this product. The classification and the summary above describe how serious the agency considers it.

Recall details

Published
January 9, 2023
Risk level
Elevated risk
Issued by
U.S. Food and Drug Administration
Brand
Spectrum
Product type
Prescription & OTC drugs
Distribution
Nationwide

Products covered by this recall

Epinephrine bulk API

What the company announced

Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API) used to manufacture or compound prescription products, to the user level. Customer complaints have found the product to be discolored.

Risk Statement: Epinephrine is a critical medication used during life-threatening conditions which can affect any age and any person. The use of a finished dose product manufactured or compounded with this recalled product could result in less-effective product, and incomplete treatment of life-threatening conditions including, low blood pressure, heart failure, anaphylaxis, irregular heartbeat, and heart attack. Treatment with a less-effective product, essentially underdosing epinephrine, could result in death. Spectrum Laboratory Products, Inc. has not received any reports of adverse events related to this recall.

Epinephrine (L-Adrenaline) USP bulk API Powder, is used in manufacturing and compounding of finished dose epinephrine prescription products which can be used to treat a variety of medical conditions including anaphylaxis and other severe immediate hypersensitivity reactions, asthma, bronchospasm, airway edema, nasal congestion, dilation during intraocular surgery, vasoconstrictor with local anesthetics, hypotension or shock, heart failure, bradycardia or atrioventricular block, and sudden cardiac arrest. The Epinephrine (L-Adrenaline) USP bulk API Powder is packaged in amber glass bottles enclosed in a vacuum sealed pouch. NDC’s, Package sizes, lot numbers and expiration dates can be found in the table below. The affected Epinephrine, USP product can be identified by Spectrum catalog number EP130. Product was distributed directly from Spectrum facilities nationwide in the USA and to Canada.

  • Product: Epinephrine, USP (Product code EP130)
  • Product: 49452-2740-2 · NDC: 1 KG · Package Size: 1KG0865 · Lot #: 31-Mar-2023
  • Product: 49452-2740-1 · NDC: 100 GM · Package Size: 2KL0353 2KF0151 · Lot #: 30-Sep-2023 31-Mar-2023
  • Product: 49452-2740-4 · NDC: 1 GM
  • Product: 49452-2740-3 · NDC: 25 GM
  • Product: 49452-2740-5 · NDC: 5 GM

Spectrum Laboratory Products, Inc. is notifying its distributors and customers by certified mail, email and phone, and arranging for return of all recalled products. Consumers, distributors, or retail pharmacies that have Epinephrine, USP catalog number EP130, which is being recalled, should stop use immediately and return to place of purchase.

Consumers with questions regarding this recall can contact Spectrum Laboratory Products, Inc. by 800-772-8786 or [email protected] on Monday to Friday from 8 am to 5 pm, pacific time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online

Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Reproduced from the company announcement posted on fda.gov. Links and contact forms in the original are not repeated here; the official notice below has them.

Check your product

The notice names 9 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.

Lot or batch code

Usually ink-stamped near the seam, the cap or the bottom of the pack.

  • 31-Mar-2023
  • 30-Sep-2023 31-Mar-2023

Model or item number

On the rating label, the box or the instruction sheet.

  • EP130
  • 49452-2740-2
  • 49452-2740-1
  • 49452-2740-4
  • 49452-2740-3
  • 49452-2740-5

Package size

Match the net weight or the piece count on the front of the pack.

  • 1 KG

Codes are lifted verbatim from the FDA — Company recall announcements notice. A code that is missing here may still be covered — the official notice is the complete list.

What to do about Drug safety

Spectrum — A problem with this medicine prompted the recall. With prescriptions, the first move is a conversation rather than a decision.

  1. Check the lot number on your pack against the codes listed above.
  2. Ask the dispensing pharmacy for a replacement from an unaffected lot.
  3. Keep the carton; the lot number is often printed only on the outer pack.
  4. Report side effects you think the product caused to FDA MedWatch.

Getting a replacement supply

Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.

  • Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
  • Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
  • Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
  • If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.

Company contact: Spectrum Laboratory Products Inc. — Consumers: Spectrum Laboratory Products, Inc., 800-772-8786, [email protected] — Media: Tej Parikh, 310-626-0654

The official notice

This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.

Open the FDA — Company recall announcements record U.S. Food and Drug Administration recalls

Questions people ask about this recall

Why was Spectrum prescription & otc drugs recalled?

Product discoloration Risk Statement: Epinephrine is a critical medication used during life-threatening conditions which can affect any age and any person.

How do I know if I have the recalled product?

Match the codes printed on your package against the notice: lot code 31-Mar-2023, 30-Sep-2023 31-Mar-2023; model number EP130, 49452-2740-2, 49452-2740-1. If the code on your package is not on that list, your unit is outside the recall.

What should I do with it right now?

Check the lot number on your pack against the codes listed above.

Can I get my money back?

Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.

Where was the recalled product sold?

It was distributed nationwide.

Related recalls